Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease

Wu K-C., Ran ZH., Gao X., Chen M., Zhong J., Sheng J-Q., Kamm MA., Travis S., Wallace K., Mostafa NM., Shapiro M., Li Y., Thakkar RB., Robinson AM.

DOI

10.5217/ir.2016.14.2.152

Type

Journal article

Journal

Intestinal Research

Publisher

Korean Association for the Study of Intestinal Diseases

Publication Date

2016

Volume

14

Pages

152 - 152

Permalink Original publication